PROGNOSIS AND RISK FACTORS IN 34 PATIENTS WITH ANCA-ASSOCIATED GLOMERULONEPHRITIS

被引：0
|
作者：
Yoshino, Atsunori [1 ]
Kaneko, Yu [1 ]
Misawa, Hideo [1 ]
Katsuhiro, Nagahori [1 ]
Kitazawa, Atsushi [1 ]
Ota, Shigeyuki [1 ]
Koda, Ryo [1 ]
Kawamoto, Shinya [1 ]
Ueda, Yoshihiko [2 ]
Takeda, Tetsuro [1 ]
机构：
[1] Dokkyo Med Univ, Koshigaya Hosp, Dept Nephrol, Saitama, Japan
[2] Dokkyo Med Univ, Koshigaya Hosp, Dept Pathol, Saitama, Japan
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2_86
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [41] Risk factors for end-stage kidney disease and death in ANCA-associated vasculitis with glomerulonephritis
    Inacio, Antonio Silva
    Pinto, Iola
    Piedade, Ana
    Domingues, Patricia
    Mendes, Beatriz
    Rios, Miriam Karina Soto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [42] HISTOLOGICAL SUBTYPING OF INTERSTITIAL INFILTRATES AND CORRELATION WITH RENAL PROGNOSIS IN ANCA-ASSOCIATED GLOMERULONEPHRITIS
    Chalkia, Aglaia
    Koutsianas, Christos
    Gakiopoulou, Harikleia
    Giannou, Panagiota
    Panagiotopoulos, Alexandros
    Kapota, Athanasia
    Thomas, Konstantinos
    Vasilopoulos, Dimitrios
    Petras, Dimitrios
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I304 - I304
  • [43] RISK FACTORS FOR MORTALITY IN ANCA-ASSOCIATED VASCULITIDES
    Bae, G. B.
    Eun, J. S.
    Kim, N. R.
    Nam, E. J.
    Kang, Y. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1090 - 1091
  • [44] Risk factors for end-stage kidney disease and death in ANCA-associated vasculitis with glomerulonephritis
    Inacio, Antonio Silva
    Pinto, Iola
    Piedade, Ana
    Domingues, Patricia
    Mendes, Beatriz
    Rios, Miriam Karina Soto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I578 - I579
  • [45] Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis
    Otsubo, S
    Nitta, K
    Uchida, K
    Yumura, W
    Nihei, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 459A - 459A
  • [46] RISK FACTORS FOR END-STAGE KIDNEY DISEASE AND DEATH IN ANCA-ASSOCIATED VASCULITIS WITH GLOMERULONEPHRITIS
    Inacio, A.
    Pinto, I.
    Piedade, A.
    Domingues, P.
    Mendes, B.
    Soto, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [47] Incidence of and risk factors for venous thromboembolism in patients with ANCA-associated vasculitis
    Stassen, P. M.
    Derks, R. P. H.
    Kallenberg, C. G. M.
    Stegeman, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 384 - 384
  • [48] What is myeloperoxidase doing in ANCA-associated glomerulonephritis?
    Couser, William G.
    Johnson, Richard J.
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 938 - 940
  • [49] MONOCYTE MIGRATION AND ACTIVATION IN ANCA-ASSOCIATED GLOMERULONEPHRITIS
    Vegting, Yosta
    Hanford, Katie
    Jongejan, Aldo
    Moerland, Perry
    Gajadin, Gayle
    van der Bom-Baylon, Nelly
    Dekker, Tamara
    Vogt, Liffert
    Bemelman, Frederike
    Kroon, Jeffrey
    Hilhorst, Andmarc
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I303 - I303
  • [50] Schistosomiasis in a Patient on Rituximab for ANCA-Associated Glomerulonephritis
    Jovanovic, Milica
    Aameish, Muhammad U.
    Baumstein, Donald I.
    Chaudhari, Ashok P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 505 - 505
12345